Skip to main content

Robotic Flight Simulator Surgery Market Insights by Target Areas, Disease Indication and Trend Analysis

Global Robotic Flight Simulator Surgery Market is presumed to expand at 11.6% CAGR during the forecast period (2017-2023) due to the rising expenditure on healthcare, asserts Market Research Future (MRFR).
Market Overview
Robotic flight stimulator surgery can be referred to as the introduction of virtual reality fundamentals to the robotic-assisted surgery. Designed with several levels of difficulties in surgical procedures, this technology offers a multi-level curriculum. A robotic flight stimulator teaches and enables the surgeons with the required skills to perform robotic surgeries.
Competitive Dashboard
The noteworthy players operating the global robotic flight simulator surgery market are Surgical (U.S.), Virtualincision (U.S.), Hansen Medical (U.S.), Interventional Systems (U.S.), Stryker (U.S.), TransEnterix (U.S.), Corindus Vascular Robots (U.S.), AVRA (U.S.), Titan Medical (Canada), Mazor Robotics (Israel), and others.
Drivers and Constraints Impacting the Market
Robotic flight stimulator offers perfection and accuracy in the procedure with less loss of blood. This has resulted in the development for robotic flight stimulator surgery market. With the increasing demand for robotic surgery and increasing expenditure on healthcare, the global market for robotic flight stimulator is considered to augment during the assessment period. Moreover, with the growing biotechnology and pharmaceutical sectors coupled with the rising prevalence of chronic diseases such as diabetes, cancer, and others, the market is presumed to propel.
Segmental Analysis
The Global Robotic Flight Simulator Surgery Market has been segmented on the basis of method, application, end-user, and region.
By mode of application, been segmented into cardiology surgery, general surgery, gynecology, neurosurgery, and others.
By mode of method, been segmented into computer control and direct telemanipulator.
By mode of end-user, been segmented into clinics, hospitals, ambulatory surgical centers, and others.
On the flip side, risk associated with robotic surgeries and high price of surgical robots are restraining the growth of the market during the assessment period. Moreover, the training required for robotic flight stimulator surgery can take away the time required to perform other surgeries which act as a major drawback.
Intended Audience
  • Pharmaceutical Companies
  • Biotechnological Institutes
  • Government and Private Laboratories
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers
Industry Updates
August 15, 2018: A London-based FundamentalVR, which makes simulation technology for medical training, is launching a new surgical flight simulator. By employing advanced haptics to mimic the real-life sensations of a number of surgical tools, the company has expected the training experience to feel less like a game and more like a real-life surgical scenario.
Regional Analysis
Geographically, the robotic flight simulator surgery market span across Europe, America, Asia Pacific, and the Middle East and Africa.
Among all the regions, America is presumed to dominate the global market for robotic flight stimulator surgery. The growth is attributed to the rising adoption of latest technologies and well-developed healthcare sector. Also, the presence of well-developed economies like Canada and the United States coupled with major industry players like Stryker, Intuitive Surgical, Hansen Medical, and others are further augmenting the market growth.
Europe is presumed to be the second largest market and is expected to maintain its dominance over the review period. The rising biotechnology and pharmaceutical sector, availability of funds for research, and increasing per capita healthcare expenditure contributing to the growth of the market in this region.
The Asia Pacific region is considered to be the fastest growing region owing to the growing demand for robotic surgeries along with the presence of huge patient population for chronic diseases like diabetes, cancer, and others. Meanwhile, the Middle East and Africa hold the least share due to the presence of poor economies, lack of proper health care services, and strict government policies in this region.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more